Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Spotify
SPOT
|
+$189M |
| 2 |
Boeing
BA
|
+$57.2M |
| 3 |
Carvana
CVNA
|
+$23.2M |
| 4 |
ConocoPhillips
COP
|
+$22.6M |
| 5 |
EXE
Expand Energy Corporation Common Stock
EXE
|
+$19.6M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$500M |
| 2 |
Microsoft
MSFT
|
+$426M |
| 3 |
Amazon
AMZN
|
+$245M |
| 4 |
Meta Platforms (Facebook)
META
|
+$194M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$167M |
Sector Composition
| 1 | Technology | 33.9% |
| 2 | Consumer Discretionary | 12.65% |
| 3 | Healthcare | 10.7% |
| 4 | Communication Services | 9.68% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2226
nLIGHT
LASR
$1.45B
| $944K | ﹤0.01% |
90,000
+1,700
| +2% | +$17.8K |
|
2227
Enliven Therapeutics
ELVN
$1.19B
| $942K | ﹤0.01% |
41,873
+5,100
| +14% | +$115K |
|
2228
Keros Therapeutics
KROS
$628M
| $934K | ﹤0.01% |
59,000
+2,700
| +5% | +$42.7K |
|
2229
Capricor Therapeutics
CAPR
$296M
| $930K | ﹤0.01% |
+67,400
| New | +$930K |
|
2230
Global Industrial
GIC
$1.48B
| $930K | ﹤0.01% |
37,500
| – | – |
|
2231
Ituran Location and Control
ITRN
$685M
| $929K | ﹤0.01% |
29,825
| – | – |
|
2232
HarborOne Bancorp
HONE
$563M
| $928K | ﹤0.01% |
78,484
| – | – |
|
2233
Grindr
GRND
$3B
| $926K | ﹤0.01% |
+51,900
| New | +$926K |
|
|
NNDM
2234
Nano Dimension
NNDM
$330M
| $925K | ﹤0.01% |
373,100
| – | – |
|
2235
Guess, Inc.
GES
$880M
| $924K | ﹤0.01% |
65,700
+12,900
| +24% | +$181K |
|
2236
Cogent Biosciences
COGT
$1.77B
| $924K | ﹤0.01% |
118,400
-3,000
| -2% | -$23.4K |
|
2237
York Water
YORW
$439M
| $923K | ﹤0.01% |
28,200
| – | – |
|
|
OLP
2238
One Liberty Properties
OLP
$501M
| $919K | ﹤0.01% |
33,752
| – | – |
|
2239
Kimball Electronics
KE
$739M
| $918K | ﹤0.01% |
49,000
| – | – |
|
2240
Tootsie Roll Industries
TR
$3B
| $917K | ﹤0.01% |
29,199
| – | – |
|
|
INVX
2241
Innovex International, Inc.
INVX
$1.14B
| $915K | ﹤0.01% |
65,500
+1,500
| +2% | +$21K |
|
2242
Portillo's
PTLO
$469M
| $915K | ﹤0.01% |
97,300
-11,000
| -10% | -$103K |
|
2243
Bar Harbor Bankshares
BHB
$536M
| $914K | ﹤0.01% |
29,900
| – | – |
|
|
BOW
2244
Bowhead Specialty Holdings
BOW
$1.07B
| $909K | ﹤0.01% |
25,600
+7,100
| +38% | +$252K |
|
2245
Erasca
ERAS
$440M
| $907K | ﹤0.01% |
361,200
+31,500
| +10% | +$79.1K |
|
|
GOOS
2246
Canada Goose Holdings
GOOS
$1.45B
| $906K | ﹤0.01% |
90,200
| – | – |
|
2247
Relay Therapeutics
RLAY
$702M
| $905K | ﹤0.01% |
219,600
| – | – |
|
2248
Arbutus Biopharma
ABUS
$784M
| $904K | ﹤0.01% |
276,300
| – | – |
|
2249
Dine Brands
DIN
$365M
| $903K | ﹤0.01% |
30,000
| – | – |
|
|
ALX
2250
Alexander's
ALX
$1.2B
| $900K | ﹤0.01% |
4,500
| – | – |
|